GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Avecho Biotechnology AVE.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.01

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Avecho Biotechnology — daily ASX:AVE

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Avecho Biotechnology on TradingView ↗
Market value
A$39.2m
Last close × shares
Volume
1.8m
Shares, 9 Nov 2026

About Avecho Biotechnology

Its shares trade on ASX under the ticker AVE.AX. It has been listed since 11 August 1993. In the fiscal year to 31 December 2025, it reported revenue of A$1.2m and a net loss of A$4.4m. At that date it held total assets of A$7.1m and shareholders' equity of A$1.6m.

Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. The company is headquartered in Melbourne, Victoria. The principal activities of the Company are the development, production, sale and licensing of products incorporating its platform technology Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care, and animal health and nutrition industries. The firm's segments include Production and Personal Care, and Human Health. The Production and Personal Care segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers delivery of drugs through gels, injectables and patches. The Human Health segment focuses on development of patches, including TPM/Oxymorphone and TPM/Oxycodone. The firm has various development programs under its animal health and nutrition. The firm has completed multiple studies assessing TPM as a feed additive in pigs and poultry.

Figures and description from our data supplier, not checked against the company's own report.

More about Avecho Biotechnology →

Latest on Avecho Biotechnology

Our reporting

We have not reported on Avecho Biotechnology yet.

Next results

3 Mar 2027

Due on 3 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Avecho Biotechnology's ticker?

Avecho Biotechnology trades as AVE.AX on ASX, under ISIN AU0000047441.

What was Avecho Biotechnology's last closing price?

0.01 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Avecho Biotechnology next report results?

Results are expected on 3 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.